Report copyright - Drug Discovery and Early Development targeting GPCRs · portfolio. 2015. Acquired Heptares Therapeutics, a UK biotech focused on GPCR drug discovery. 2018. TODAY. Corporate rebranding
Please pass captcha verification before submit form